Famous Patents
In 1879, Auguste Bartholdi received design patent number 11,023 titled "Design for a Statue". It was for the Statue of Liberty.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120045422 | USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT ECZEMA Use of Lactobacillus rhamnosus HN001 or derivatives thereof to treat or prevent eczema.... | 02/23/2012 |
| 20120039852 | LACTOBACILLUS RHAMNOSUS NCC4007, A PROBIOTIC MIXTURE AND WEIGHT CONTROL The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat or prevent obesity. One embodiment of the present invention relates to the... | 02/16/2012 |
| 20120040014 | LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders Nutritional supplement formulations suitable for specific enhancement of cell and mitochondrial function comprise enriched formulations of phospholipids and chemical precursors containing specifically identified concentrations of phosphatidylglycerol, phosphatidic acid ... | 02/16/2012 |
| 20120040829 | BACTERIAL GHOSTS AS CARRIER AND TARGETING VEHICLES The invention concerns the use of bacterial ghosts as carrier and targeting vehicles for active substances.... | 02/16/2012 |
| 20120034264 | INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.... | 02/09/2012 |
| 20120027737 | USE OF PROBIOTICS TO AMELIORATE DIET-INDUCED INSULIN RESISTANCE The invention relates to the use of a composition comprising probiotic bacteria that regulate expression of key components involved in diet-induced insulin resistance for ameliorating or preventing diet-induced insulin resistance. The use of the probiotic strain and/or ... | 02/02/2012 |
| 20120020944 | USE OF A PROBIOTIC TO REGULATE BODY WEIGHT The use of probiotic bacteria that modulate expression of a number of satiety markers in the intestine and reduces fat deposition to promote an optimal body weight of a mammal is described. The invention further relates to a composition comprising such a probiotic strai... | 01/26/2012 |
| 20110311502 | AGENT FOR PREVENTION OR AMELIORATION OF OBESITY To provide a pharmaceutical product or food which has an excellent fat-accumulation-inhibiting activity and/or fat-metabolism-improving activity and which is effective for inhibition or improvement of obesity, fatty liver, etc. The present ... | 12/22/2011 |
| 20110306494 | COMPOSITION BASED ON BACILLUS SPP. AND CORRELATE GENERA AND THEIR USE IN PEST CONTROL The objective of the current invention is the control of agricultural infestations based on alternative methods that are less aggressive to the environment and that are harmless to other invertebrates and to man; for instance biological control using bacterial strains b... | 12/15/2011 |
| 20110300225 | NUTRITIONAL COMPOSITIONS WITH COATED LIPID GLOBULES The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a lipid globules coated with phospholipids. The composition is used for increasing bone mineral content, bone mineral density, preventing osteop... | 12/08/2011 |
| 20110300204 | NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a large lipid globule size, having a volume weighted mode diameter above 1.0 μm and/or with a diameter of 2 to 12 μm in a amount of at least 4... | 12/08/2011 |
| 20110293521 | Anti-viral compositions and methods for administration Certain embodiments disclosed relate to compositions, including therapeutic compositions, methods, articles of manufacture, systems, and devices. Certain embodiments relate to anti-viral compositions, methods, articles of manufacture, systems and devices.... | 12/01/2011 |
| 20110293569 | LACTOBACILLUS RHAMNOSUS CNCM I-4096 AND WEIGHT CONTROL The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity. One embodiment of the present invention relates to the use of Lactobaci... | 12/01/2011 |
| 20110293722 | HYDROGEL SPONGES, METHODS OF PRODUCING THEM AND USES THEREOF A macroporous hydrogel sponge is provided selected from: (i) a synthetic polymer hydrogel sponge, and (ii) a synthetic polymer-polypeptide conjugate hydrogel sponge, the macroporous hydrogel sponge being at least 20% porous and having a pore diameter of 50-1000 μm, whe... | 12/01/2011 |
| 20110280978 | COSMETIC USE OF BOTULINUM TOXIN FOR THE TREATMENT OF EYEBROW AND FOREHEAD PTOSIS, AND UNWANTED EYEBROW EXPRESSION A method of temporarily elevating the eyebrow position and softening undesirable glabellar muscle activity to affect a more desirable appearance. In a broad aspect the invention comprises injecting small quantities of botulinum toxin (BTX) dissolved in microdroplets of ... | 11/17/2011 |
| 20110268829 | QUALITY OF LIFE FOR HEPATITIS C PATIENTS WITH A FORMULATION FOR ADMINISTRATION TO THE ORAL MUCOSA INCLUDING LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS AND N-ACETYL D-GLUCOSAMINE Disclosed are quick dissolve tablets, each including Lactobacillus delbrueckii subsp bulgaricus (LBD) and N-acetyl-glucosamine (NAG), as well as excipients, for oral mucosal administration, for improving the quality of life of Hepatitis C patients. Any for... | 11/03/2011 |
| 20110268828 | CELL RECEPTOR BLOCKER FOR PREVENTING AND TREATING AVIAN INFLUENZA AND OTHER DISEASES CAUSED BY VIRUSES Use of previously inactivated viral particles of the avian influenza virus or of previously purified antigenic components thereof, alone or in combination with carriers of biological origin in a composition administered via the respiratory system in order to prevent and... | 11/03/2011 |
| 20110262416 | Bacillus subtilis strain having antagonistic activity for controlling plant diseases A novel strain of Bacillus subtilis EB120 shows high antagonistic activity for controlling various plant diseases including barley powdery mildew, cucumber powdery mildew, red pepper anthracnose, rice blast, tomato gray mold, tomato late blight and wheat leaf rus... | 10/27/2011 |
| 20110250276 | Cosmetic Composition Containing Acetylated Oligoglucuronans The present invention relates to the field of cosmetic and dermopharmaceutical compositions. It concerns oligomer compounds of D-glucuronic acid or D-glucuronate with a β (1-4) sequence (or oligoglucuronans) containing a degree of acetylation specifically between 8.7±... | 10/13/2011 |
| 20110223262 | Method of Enhancing Biological Activity of Plant Extracts The present invention relates to a method of modulating a selected biological activity of a naturally occurring material having one or more biological activities in an extract of the naturally occurring material, the method comprising incubating the extract in a medium ... | 09/15/2011 |
| 20110217402 | Probiotic Derived Non-Viable Material For Allergy Prevention And Treatment A process for the preparation of a non-viable probiotic composition having anti-allergic (i.e. allergy preventive and/or anti-allergic in a therapeutic sense) properties, the process including the steps of (a) subjecting LGG to cultivation in a suitable culture medium u... | 09/08/2011 |
| 20110217368 | BACTERIAL COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF DEGENERATIVE DISEASE The disclosure provides an oral composition for reducing serum cholesterol, serum lipids, body fat, or atherogenic index or for prophylaxis or treatment of atherosclerosis, cardiovascular or cerebrovascular diseases, comprising a highly bsh active bacteria, isolate or s... | 09/08/2011 |
| 20110206723 | USE OF PLANT CELL MEMBRANE FOR THE TREATMENT OF OBESITY The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention als... | 08/25/2011 |
| 20110195051 | USE OF BACTERIA OF THE GENUS TENACIBACULUM FOR QUORUM QUENCHING Use of bacterial cells of the genus Tenacibaculum, from the crude cellular extract or from its cultivation supernatants, capable of degrading N-acyl homoserine lactones, for quorum quenching, for treatment of infectious bacterial illnesses or to inhibit formation... | 08/11/2011 |
| 20110195103 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING PSEUDOALTEROMONAS FERMENT EXTRACT Cosmetic or dermopharmaceutical compositions containing Pseudoalteromonas ferment extract for the treatment and/or care of the skin, scalp and/or nails, preferably to improve the barrier function of the skin, scalp and/or nails, and specifically for the treatment... | 08/11/2011 |
| 20110189323 | COSMETIC COMPOSITIONS There is disclosed a skincare composition suitable for topical application to the skin. The composition comprises two or more active ingredients selected from the group consisting of a) dipalmitoyl hydroxyproline, salts and esters thereof; b) carnitine; and c) an extrac... | 08/04/2011 |
| 20110182847 | USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS Improved (safer and more effective) methods of therapy using TNF-R agonists, e.g., CD40 agonists are provided. These methods provide for the addition of an amount of a type 1 interferon and/or a TLR agonist that is effective to prevent or reduce the toxicity (liver toxi... | 07/28/2011 |
| 20110183021 | Compositions Containing Purine Nucleosides and Manganese and Their Uses This invention encompasses methods of preserving protein function by contacting a protein with a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese). In addition, the invention encompass... | 07/28/2011 |
| 20110177185 | PHARMACEUTICALLY COMPATIBLE METHOD FOR PURIFYING INTACT BACTERIAL MINICELLS The present invention provides a method for purifying bacterial minicells that involves subjecting a sample containing minicells to density gradient centrifugation in a biologically compatible medium. The method optionally includes a preliminary differential centrifugat... | 07/21/2011 |
| 20110171334 | ANTIBACTERIAL SUBSTANCE DM0507 AND UTILIZATION OF THE SAME An object is to provide a more potent novel antimicrobial active substance, which is derived from a naturally occurring substance and has a broad antimicrobial spectrum, and an antimicrobial active substance DM0507 obtained by a production process comprising the followi... | 07/14/2011 |
| 20110159131 | USE OF STRAINS OF LACTOBACILLUS AND BY-PRODUCTS THEREOF FOR INHIBITING FORMATION OF BLOOD VESSELS A lactic composition containing at least a bacterial strain selected from the group consisting of Lactobacillus acidophilus, Lactobacillus casei and a mixture of Lactobacillus acidophilus and Lactobacillus casei, and a whole broth of the bacterial s... | 06/30/2011 |
| 20110159130 | REDUCTION OF ENDOTOXIN IN POLYSIALIC ACIDS The present invention relates to process for reducing the endotoxin content of a sample of fermentation broth containing polysialic acid and endotoxin comprising the sequential steps: (i) adding to the sample a base having a pKa of at least 12 to form a basic solution h... | 06/30/2011 |
| 20110150943 | ADHESIVE FOR MEDICAL APPLICATIONS AND MEANS FOR HAEMOSTASIS The invention relates to adhesives for medical applications and methods of their preparation and use.... | 06/23/2011 |
| 20110150852 | Novel Strain of Lactobacillus Paracasei Subspecies Paracasei Having Antimicrobial and Immunomodulatory Properties The invention relates to a novel strain of Lactobacillus paracasei subspecies paracasei, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.... | 06/23/2011 |
| 20110150952 | EXTEMPORANEOUS CARE PRODUCT BASED ON A LYOPHILIZATE OF MICROORGANISMS AND SURFACTANT(S) WITH AN HLB GREATER THAN OR EQUAL TO 12 The present invention relates to a method for the cosmetic treatment of a keratin material comprising at least the steps of: (a) having available a lyophilizate containing at least one live or inactivated, physiologically acceptable microorganism, one of its metabolites... | 06/23/2011 |
| 20110123576 | INTESTINAL ENVIRONMENT-IMPROVING AGENT Disclosed is an intestinal environment-improving agent including a lactoferrin and bacteria of Lactobacillus brevis as effective ingredients.... | 05/26/2011 |
| 20110117160 | ANTAGONISTIC PROPERTIES OF REEF FISH MICROFLORA The present invention provides methods for preventing biofilm formation on a surface. The present invention also relates to anti-biofilm forming agents, to methods of producing and using them, and to anti-fouling coatings produced therefrom.... | 05/19/2011 |
| 20110117180 | VEGETARIAN MICROCAPSULES Disclosed are microcapsules with shells that are not animal by-products and methods for preparing and using such microcapsules.... | 05/19/2011 |
| 20110117068 | PROBIOTIC MICROORGANISMS FOR THE REDUCTION OF MANURE ODOR Described are microorganism which are able to reduce the generation of feces odor by decreasing the amount of at least one of the compounds methyl mercaptan, a sulphide compound, cadavarine, putrescine, indole or skatole, and wherein said decrease in the amount of said ... | 05/19/2011 |
| 20110110989 | OIL-IN-WATER EMULSION COMPRISING AN AMPHIPHILIC POLYMER The present patent application relates to a composition for topical application in the form of an oil-in-water emulsion comprising an oily phase dispersed in an aqueous phase, characterized in that it comprises at least one noncrosslinked amphiphilic polymer, the globul... | 05/12/2011 |
